According to a recent analysis by Future Market Insight, the global antiepileptic drug market is set for substantial growth, with an estimated valuation of USD 18.85 billion in 2024 and projected to reach USD 28.72 billion by 2034. This represents a compound annual growth rate (CAGR) of 4.3% over the forecast period. Epilepsy, a neurological …